Effects of growth hormone and prolactin immune development and function.

[1]  R. Badolato,et al.  Differential expression of surface membrane growth hormone receptor on human peripheral blood lymphocytes detected by dual fluorochrome flow cytometry. , 1994, The Journal of clinical endocrinology and metabolism.

[2]  H. Rui,et al.  JAK2 activation and cell proliferation induced by antibody-mediated prolactin receptor dimerization. , 1994, Endocrinology.

[3]  C. Reymundo,et al.  Effects of growth hormone and prolactin on testicular macrophages in long-term hypophysectomized rats. , 1994, Journal of reproductive immunology.

[4]  M. Fujimoto,et al.  Growth hormone and insulin-like growth factor I induce immunoglobulin (Ig)E and IgG4 production by human B cells , 1994, The Journal of experimental medicine.

[5]  D. Taub,et al.  Growth hormone promotes human T cell adhesion and migration to both human and murine matrix proteins in vitro and directly promotes xenogeneic engraftment. , 1994, The Journal of clinical investigation.

[6]  A. Walker.  Phosphorylated and nonphosphorylated prolactin isoforms , 1994, Trends in Endocrinology & Metabolism.

[7]  G. Freund,et al.  Functional insulin and insulin-like growth factor-1 receptors are preferentially expressed in multiple myeloma cell lines as compared to B-lymphoblastoid cell lines. , 1994, Cancer research.

[8]  R. Clark,et al.  In vivo administration of insulin-like growth factor-I stimulates primary B lymphopoiesis and enhances lymphocyte recovery after bone marrow transplantation. , 1994, Journal of immunology.

[9]  H. Kimata,et al.  Differential effect of growth hormone and insulin-like growth factor-I, insulin-like growth factor-II, and insulin on Ig production and growth in human plasma cells , 1994 .

[10]  W. Farrar,et al.  Activation of receptor-associated tyrosine kinase JAK2 by prolactin. , 1994, The Journal of biological chemistry.

[11]  J. Schlessinger.  SH2/SH3 signaling proteins. , 1994, Current opinion in genetics & development.

[12]  G. Yancopoulos,et al.  Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. , 1994, Science.

[13]  J. Dunbar,et al.  Prolactin modulates the incidence of diabetes in male and female NOD mice. , 1994, Autoimmunity.

[14]  L. Gibson,et al.  Insulin-like growth factor-1 potentiates expansion of interleukin-7-dependent pro-B cells. , 1993, Blood.

[15]  E. Shevach,et al.  Identification by analytical flow cytometry of prolactin receptors on immunocompetent cell populations in the mouse. , 1993, Endocrinology.

[16]  R. Clark,et al.  Insulin-like growth factor-1 stimulation of lymphopoiesis. , 1993, The Journal of clinical investigation.

[17]  C. Wiedermann,et al.  Stimulation of monocyte chemotaxis by human growth hormone and its deactivation by somatostatin. , 1993, Blood.

[18]  O. Silvennoinen,et al.  JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin , 1993, Cell.

[19]  O. Silvennoinen,et al.  Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase , 1993, Cell.

[20]  D. Longo,et al.  Differential effects of growth hormone and prolactin on murine T cell development and function , 1993, The Journal of experimental medicine.

[21]  P. Kelly,et al.  Expression of prolactin receptors in murine lymphoid cells in normal and autoimmune situations. , 1993, Journal of immunology.

[22]  A. Mastro,et al.  Prolactin receptors are found on heterogeneous subpopulations of rat splenocytes. , 1993, Endocrinology.

[23]  E. Shevach,et al.  Influence of bromocriptine administration to mothers on the development of pup thymocyte and splenocyte subsets and on mitogen-induced proliferation in the mouse. , 1993, Life sciences.

[24]  A. Johnson,et al.  In vivo activation of macrophages by prolactin from young and aging mice. , 1993, International journal of immunopharmacology.

[25]  D. Longo,et al.  Role of neuroendocrine hormones in murine T cell development. Growth hormone exerts thymopoietic effects in vivo. , 1992, Journal of immunology.

[26]  D. Longo,et al.  Recombinant human growth hormone promotes human lymphocyte engraftment in immunodeficient mice and results in an increased incidence of human Epstein Barr virus-induced B-cell lymphoma , 1992, Brain, Behavior, and Immunity.

[27]  P. Kelly,et al.  Prolactin receptor triggering. Evidence for rapid tyrosine kinase activation. , 1992, The Journal of biological chemistry.

[28]  D. Longo,et al.  Growth hormone exerts hematopoietic growth-promoting effects in vivo and partially counteracts the myelosuppressive effects of azidothymidine. , 1992, Blood.

[29]  K. Dorshkind,et al.  Insulin-like growth factor-I regulates pro-B cell differentiation , 1992 .

[30]  M. Rosenfeld,et al.  Anterior pituitary development: Short tales from dwarf mice , 1992, Cell.

[31]  D. Goeddel,et al.  Rational design of potent antagonists to the human growth hormone receptor. , 1992, Science.

[32]  D. Longo,et al.  Immunologic and hematologic effects of neuroendocrine hormones. Studies on DW/J dwarf mice. , 1992, Journal of immunology.

[33]  T. Roszman,et al.  Immunologic disparity in the hypopituitary dwarf mouse. , 1992, Journal of immunology.

[34]  M. Ultsch,et al.  Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. , 1992, Science.

[35]  J. Laurence,et al.  Effect of recombinant human growth hormone on acute and chronic human immunodeficiency virus infection in vitro. , 1992, Blood.

[36]  K. Clauser,et al.  Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. , 1991, Science.

[37]  Héctor Pulido,et al.  ENHANCEMENT OF THYMIC RECOVERY AFTER CYCLOSPORINE BY RECOMBINANT HUMAN GROWTH HORMONE AND INSULIN‐LIKE GROWTH FACTOR I , 1991, Transplantation.

[38]  P. Kelly,et al.  A prolactin-dependent immune cell line (Nb2) expresses a mutant form of prolactin receptor. , 1991, The Journal of biological chemistry.

[39]  D. Longo,et al.  Anti-IgM-mediated growth inhibition of a human B lymphoma cell line is independent of phosphatidylinositol turnover and protein kinase C activation and involves tyrosine phosphorylation. , 1991, Journal of immunology.

[40]  P. Kelly,et al.  The prolactin/growth hormone receptor family. , 1991, Endocrine reviews.

[41]  J. Stephenson,et al.  Adjuvant effect of human growth hormone with an inactivated flavivirus vaccine. , 1991, The Journal of infectious diseases.

[42]  A. Cesano,et al.  Prolactin and the neuroimmune network , 1991 .

[43]  R. Furlanetto,et al.  Insulin-like growth factor-I binds selectively to human peripheral blood monocytes and B-lymphocytes. , 1991, The Journal of clinical endocrinology and metabolism.

[44]  S. Bass,et al.  Zinc mediation of the binding of human growth hormone to the human prolactin receptor. , 1990, Science.

[45]  C. Clevenger,et al.  Interleukin-2 driven nuclear translocation of prolactin in cloned T-lymphocytes. , 1990, Endocrinology.

[46]  S. Volkman,et al.  Insulin-like growth factor-I supports proliferation of autocrine thymic lymphoma cells with a pre-T cell phenotype. , 1990, Journal of immunology.

[47]  P. Kelly,et al.  Mitogenic and binding properties of monoclonal antibodies to the prolactin receptor in Nb2 rat lymphoma cells. Selective enhancement by anti-mouse IgG. , 1990, The Journal of biological chemistry.

[48]  A. Mastro,et al.  Prolactin induction of interleukin-2 receptors on rat splenic lymphocytes. , 1990, Endocrinology.

[49]  P. Sönksen,et al.  The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. , 1989, The New England journal of medicine.

[50]  J. Holaday,et al.  Inhibition of lymphocyte proliferation by antibodies to prolactin 1 , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[51]  J. Bach,et al.  Neuroendocrine control of thymic hormonal production. I. Prolactin stimulates in vivo and in vitro the production of thymulin by human and murine thymic epithelial cells. , 1989, Endocrinology.

[52]  K. Kelley,et al.  Growth hormone, lymphocytes and macrophages. , 1989, Biochemical pharmacology.

[53]  P. Pilch,et al.  Structural and functional characterization of the human T lymphocyte receptor for insulin-like growth factor I in vitro. , 1988, The Journal of clinical investigation.

[54]  W. Kiess,et al.  Lymphocyte subset distribution and natural killer activity in growth hormone deficiency before and during short-term treatment with growth hormone releasing hormone. , 1988, Clinical immunology and immunopathology.

[55]  A. Cesano,et al.  Prolactin receptors on large granular lymphocytes: Dual regulation by cyclosporin A , 1988, Brain, Behavior, and Immunity.

[56]  K. Kelley,et al.  A newly defined property of somatotropin: priming of macrophages for production of superoxide anion. , 1988, Science.

[57]  J. Holaday,et al.  Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice. , 1988, Science.

[58]  J. Kraner,et al.  Exogenous growth hormone treatment alters body composition and increases natural killer cell activity in women with impaired endogenous growth hormone secretion. , 1987, Metabolism: clinical and experimental.

[59]  J. Oleske,et al.  Effects of human growth hormone on immune functions: in vitro studies on cells of normal and growth hormone-deficient children. , 1987, Life sciences.

[60]  R. Hammer,et al.  Role of growth hormone in regulating T‐Dependent immune events in aged, nude, and transgenic rodents , 1987, Journal of neuroscience research.

[61]  H. Friesen,et al.  The nature and regulation of the receptors for pituitary growth hormone. , 1985, Annual review of physiology.

[62]  S. Gupta,et al.  Immunological studies in patients with isolated growth hormone deficiency. , 1983, Clinical and experimental immunology.

[63]  M. Gershwin,et al.  Immunologic Defects in Laboratory Animals 2 , 1981 .

[64]  D. Golde,et al.  Growth hormone stimulation of normal and leukemic human T-lymphocyte proliferation in vitro. , 1981, Blood.

[65]  E. C. Snow,et al.  The effect of growth hormone and insulin upon MLC responses and the generation of cytotoxic lymphocytes. , 1981, Journal of immunology.

[66]  F. Dumont,et al.  T and B lymphocytes in pituitary dwarf Snell-Bagg mice. , 1979, Immunology.

[67]  S. Arrenbrecht.  Specific binding of growth hormone to thymocytes , 1974, Nature.

[68]  R. Duquesnoy.  Immunodeficiency of the thymus-dependent system of the Ames dwarf mouse. , 1972, Journal of immunology.

[69]  E. Sorkin,et al.  Hormones and the immunological capacity. 3. The immunodeficiency disease of the hypopituitary Snell-Bagg dwarf mouse. , 1971, Clinical and experimental immunology.

[70]  E. Sorkin,et al.  Hormones and the immunological capacity. IV. Restorative effects of developmental hormones or of lymphocytes on the immunodeficiency syndrome of the dwarf mouse. , 1971, Clinical and experimental immunology.

[71]  N. Fabris,et al.  Effects of hormones on development and function of lymphoid tissues. Synergistic action of thyroxin and somatotropic hormone in pituitary dwarf mice. , 1969, Immunology.

[72]  E. Sorkin,et al.  Hormones and immunological capacity. II. Reconstitution of antibody production in hormonally deficient mice by somatotropic hormone, thyrotropic hormone and thyroxin. , 1969, Immunology.

[73]  E. Sorkin,et al.  Hormones and immunologic capacity. I. Effect of heterologous anti-growth hormone (ASTH) antiserum on thymus and peripheral lymphatic tissue in mice. Induction of a wasting syndrome. , 1968, Journal of immunology.